Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7474 427
20 October 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


CPS manifesto calls for pharmacist access to electronic records

Community Pharmacy Scotland is lobbying politicians with the aim of obtaining access for community pharmacists to electronic patient records.

The call is made in the new CPS manifesto launched this week, which sets out the organisation’s vision for the future of community pharmacy, and which has been sent to politicians and policy makers.

On patient records, the manifesto states: “CPS maintains that the ability to make better use of community pharmacists’ key skills, to make valuable contribution to the management of chronic disease and to ensure effective pharmacist independent prescribing, is dependent on community pharmacists having access to appropriate parts of the electronic patient record.”

Martin Green, CPS chairman, added: “We believe our members need to have as much information on patients as possible with regard to their medication in the interests of safety. We regard appropriate access to electronic patient records as essential.”

The manifesto seeks political support in eight areas: new clinical roles for community pharmacists; pharmacist independent prescribing; access to electronic patient records; pharmacists’ public health role; community pharmacist representation in policy development; pharmacy involvement in development of unscheduled care services; investment in premises, technology and training; and maintenance of the viability of the medicines distribution network.

On public health, CPS wants smoking cessation and emergency hormonal contraception services to be part of the national pharmacy contract. And on medicines distribution it says: “CPS asks that politicians and NHS policy makers support the principle of manufacturers’ medicines being available to all Scottish and indeed UK wholesalers. CPS believes that the continued viability of the wholesaler networks is vital to the continuity of patient care in Scotland.”

Back to Top


©The Pharmaceutical Journal